bpc 157 typical cycle length dosage protocol BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 Cost 2026: Real Pricing
Description
AOD-9604 is a 16-amino-acid synthetic peptide

The compound is not intended for human or veterinary clinical use and is supplied exclusively for scientific investigation

MMA, unlike homocysteine, is not influenced by folate or vitamin B6

Sourcing these compounds from research chemical suppliers remains in the same legal gray area it has been in since September 2023

Refrigerate at 28 C immediately after reconstitution
